Company · CIK 0000791908 · SIC 2834 — Pharmaceutical Preparations
XOMA Royalty Corp · XOMA
Insider activity reported against this company. All insider holders · Files at: RZLT. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 6, 2015 DMForm 4 → | Apr 7, 7:20 pm EDT | Fred KurlandCFO & VP Finance | 65,213 | $3.61 | $127,251 | 75,461 | — | plan? |
| Mar 31, 2015 JForm 5 → | Feb 16, 2016, 5:36 pm EST | James R NealOther | 15,517 | $1.65 | $25,611 | 13,192 | — | plan? |
| Mar 31, 2015 JForm 5 → | Feb 16, 2016, 5:33 pm EST | Paul D RubinSr. VP Clinical Dev. & CMO | 8,573 | $1.88 | $16,158 | 13,422 | — | plan? |
| Mar 23, 2015 SForm 4 → | Mar 23, 6:35 pm EDT | Paul D RubinSr. VP Clinical Dev. & CMO | 32,742 | $3.94 | $128,879 | 119,467 | −21.5% | plan? |
| Mar 18, 2015 DMForm 4 → | Mar 20, 7:30 pm EDT | Patrick J Scannon M.D. Ph.D.Exec. VP & CSO, Director | 18,166 | $4.01 | $34,755 | 116,120 | — | plan? |
| Mar 18, 2015 DMForm 4 → | Mar 20, 7:30 pm EDT | Thomas KleinChief Commercial Officer | 133,704 | $4.01 | $212,705 | 185,680 | — | plan? |
| Mar 18, 2015 DMForm 4 → | Mar 20, 7:30 pm EDT | Paul D RubinSr. VP Clinical Dev. & CMO | 50,881 | $4.01 | $82,356 | 152,209 | — | plan? |
| Mar 18, 2015 DForm 4 → | Mar 20, 7:30 pm EDT | James R NealOther | 9,019 | $4.01 | $36,171 | 184,469 | — | plan? |
| Mar 18, 2015 DMForm 4 → | Mar 20, 7:30 pm EDT | Fred KurlandCFO & VP Finance | 20,038 | $4.01 | $36,748 | 80,798 | — | plan? |
| Mar 18, 2015 DMForm 4 → | Mar 20, 7:30 pm EDT | John VarianCEO, Director | 81,784 | $4.01 | $179,979 | 552,414 | — | plan? |
| Mar 16, 2015 SForm 4 → | Mar 17, 6:52 pm EDT | John VarianCEO, Director | 10,000 | $3.72 | $37,223 | 560,384 | −1.75% | plan? |
| Mar 16, 2015 MForm 4 → | Mar 17, 6:52 pm EDT | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 570,384 | — | plan? |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:42 pm EST | John VarianCEO, Director | 193,200 | — | — | 560,384 | — | plan? |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:42 pm EST | Thomas KleinChief Commercial Officer | 64,900 | — | — | 158,050 | — | plan? |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:42 pm EST | Fred KurlandCFO & VP Finance | 10,000 | — | — | 79,086 | — | plan? |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:42 pm EST | James R NealOther | 52,500 | — | — | 193,488 | — | plan? |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:42 pm EST | Patrick J Scannon M.D. Ph.D.Exec. VP & CSO, Director | 38,940 | — | — | 115,286 | — | plan? |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:41 pm EST | Paul D RubinSr. VP Clinical Dev. & CMO | 64,900 | — | — | 142,398 | — | plan? |
| Feb 17, 2015 SForm 4 → | Feb 19, 6:09 pm EST | John VarianCEO, Director | 10,000 | $3.52 | $35,192 | 367,184 | −2.65% | plan? |
| Feb 17, 2015 MForm 4 → | Feb 19, 6:09 pm EST | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 377,184 | — | plan? |
| Feb 3, 2015 GForm 4 → | Feb 4, 5:36 pm EST | Fred KurlandCFO & VP Finance | 16,000 | — | — | 69,086 | — | plan? |
| Feb 2, 2015 SForm 4 → | Feb 3, 1:38 pm EST | Patrick J Scannon M.D. Ph.D.Exec. VP & CSO, Director | 5,000 | $3.52 | $17,622 | 76,346 | −6.15% | plan? |
| Jan 15, 2015 SForm 4 → | Jan 16, 5:22 pm EST | John VarianCEO, Director | 10,000 | $3.46 | $34,582 | 367,184 | −2.65% | plan? |
| Jan 15, 2015 MForm 4 → | Jan 16, 5:22 pm EST | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 377,184 | — | plan? |
| Jan 2, 2015 SForm 4 → | Jan 6, 8:31 pm EST | BAKER BROS. ADVISORS LP +6Director, 10% Owner | 2,215,400 | $3.81 | $8,437,818 | 345,074 | −86.5% | plan? |
| Jan 2, 2015 SForm 4 → | Jan 5, 5:32 pm EST | Patrick J Scannon M.D. Ph.D.Exec. VP & CSO, Director | 5,000 | $3.55 | $17,756 | 81,346 | −5.79% | plan? |
| Dec 31, 2014 JForm 5 → | Feb 17, 2015, 6:15 pm EST | Fred KurlandCFO & VP Finance | 3,001 | $3.83 | $11,498 | 22,137 | — | plan? |
| Dec 31, 2014 JForm 5 → | Feb 17, 2015, 6:15 pm EST | Patrick J Scannon M.D. Ph.D.Exec. VP & CSO, Director | 3,001 | $3.83 | $11,498 | 25,080 | — | plan? |
| Dec 31, 2014 JForm 5 → | Feb 17, 2015, 6:15 pm EST | John VarianCEO, Director | 3,001 | $3.83 | $11,498 | 18,538 | — | plan? |
| Dec 31, 2014 JForm 5 → | Feb 17, 2015, 6:15 pm EST | Thomas KleinChief Commercial Officer | 3,001 | $3.83 | $11,498 | 4,660 | — | plan? |
| Mar 31, 2014 JForm 5 → | Feb 17, 2015, 6:15 pm EST | James R NealOther | 6,229 | $4.07 | $25,344 | 4,471 | — | plan? |
| Dec 31, 2013 JForm 5 → | Feb 17, 2015, 6:14 pm EST | Paul D RubinSr. VP Clinical Dev. & CMO | 4,579 | $4.29 | $19,656 | 6,881 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Maricel Perea MontanoChief Legal Officer | 48,390 | — | — | 0 | — | |
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Joseph M LimberDirector | 74,500 | — | — | 0 | — | |
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Barbara KosaczDirector | 69,125 | — | — | 0 | — | |
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Jack L WyszomierskiDirector | 54,801 | — | — | 0 | — | |
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Owen HughesChief Executive Officer, Director | 423,959 | — | — | 0 | — | |
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Natasha HerndayDirector | 43,196 | — | — | 0 | — | |
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Bradley SitkoChief Investment Officer | 614,600 | — | — | 0 | — | |
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Matthew D PerryDirector | 59,657 | — | — | 0 | — | |
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Jeffrey TrigilioChief Financial Officer | 152,924 | — | — | 0 | — | |
| Jul 14, 2026 DForm 4 → | Jul 14, 9:45 pm EDT | Heather L FranklinDirector | 47,008 | — | — | 0 | — | |
| Feb 13, 2019 AForm 4 → | Feb 15, 5:01 pm EST | Deepshikha DattaChief Business Officer | 50,000 | — | — | 50,000 | — | |
| Feb 13, 2019 AForm 4 → | Feb 15, 5:01 pm EST | Thomas M. BurnsSVP, Finance & CFO | 23,000 | — | — | 23,000 | — | |
| Feb 13, 2019 AForm 4 → | Feb 15, 5:00 pm EST | James R NealCEO, Director | 60,000 | — | — | 60,000 | — | |
| Jan 1, 2019 AForm 4 → | Jan 3, 6:50 pm EST | Barbara KosaczDirector | 19,979 | — | — | 19,979 | — | |
| Dec 20, 2018 XForm 4 → | Dec 21, 6:24 pm EST | James R NealCEO, Director | 678 | — | — | 0 | — | |
| Dec 20, 2018 XForm 4 → | Dec 21, 6:22 pm EST | W Denman Van NessDirector | 800 | — | — | 0 | — | |
| Dec 14, 2018 XForm 4 → | Dec 19, 9:26 pm EST | BVF PARTNERS L P/IL +610% Owner | 1,823 | $13,000.00 | $16,286,036 | 597 | — | late |
| Nov 15, 2018 MForm 4 → | Nov 16, 4:31 pm EST | W Denman Van NessDirector | 7,693 | — | — | 0 | — | |
| Jul 19, 2018 AForm 4 → | Jul 23, 5:56 pm EDT | Deepshikha DattaChief Business Officer | 24,000 | — | — | 24,000 | — | |
| May 17, 2018 AForm 4 → | May 21, 9:16 pm EDT | Joseph M LimberDirector | 5,052 | — | — | 5,052 | — | |
| May 17, 2018 AForm 4 → | May 21, 9:16 pm EDT | W Denman Van NessDirector | 5,052 | — | — | 5,052 | — | |
| May 17, 2018 AForm 4 → | May 21, 9:15 pm EDT | Jack L WyszomierskiDirector | 5,052 | — | — | 5,052 | — | |
| May 17, 2018 AForm 4 → | May 21, 8:53 pm EDT | Matthew D PerryDirector | 5,052 | — | — | 5,052 | — | |
| Apr 26, 2018 MForm 4 → | Apr 27, 5:44 pm EDT | Thomas M. BurnsSVP, Finance & CFO | 11,000 | — | — | 24,000 | — | |
| Apr 26, 2018 MForm 4 → | Apr 27, 5:44 pm EDT | James R NealCEO, Director | 24,000 | — | — | 76,000 | — | |
| Mar 27, 2018 AForm 4 → | Mar 29, 5:11 pm EDT | Deepshikha DattaChief Business Officer | 80,000 | — | — | 80,000 | — | |
| Feb 14, 2018 AForm 4 → | Feb 16, 5:28 pm EST | James R NealCEO, Director | 30,000 | — | — | 30,000 | — | |
| Feb 14, 2018 AForm 4 → | Feb 16, 5:28 pm EST | Thomas M. BurnsSVP, Finance & CFO | 25,000 | — | — | 25,000 | — | |
| Nov 13, 2017 MForm 4 → | Nov 15, 8:03 pm EST | James R NealCEO, Director | 46,296 | — | — | 266,204 | — | |
| Nov 13, 2017 MForm 4 → | Nov 15, 8:03 pm EST | Thomas M. BurnsSVP, Finance & CFO | 22,222 | — | — | 77,778 | — | |
| Sep 15, 2017 AForm 4 → | Feb 28, 2018, 6:26 pm EST | Joseph M LimberDirector | 2,366 | — | — | 2,366 | — | late |
| Sep 15, 2017 AForm 4 → | Feb 28, 2018, 6:23 pm EST | Jack L WyszomierskiDirector | 2,366 | — | — | 2,366 | — | late |
| Sep 15, 2017 AForm 4 → | Feb 28, 2018, 6:23 pm EST | W Denman Van NessDirector | 2,366 | — | — | 2,366 | — | late |
| Mar 2, 2017 AForm 4 → | Mar 7, 7:47 pm EST | Matthew D PerryDirector | 15,222 | — | — | 15,222 | — | late |
| Feb 10, 2017 AForm 4 → | May 22, 6:48 pm EDT | Jack L WyszomierskiDirector | 8,000 | — | — | 8,000 | — | late |
| Feb 10, 2017 AForm 4 → | May 22, 6:45 pm EDT | Timothy P WalbertDirector | 8,000 | — | — | 8,000 | — | late |
| Feb 10, 2017 AForm 4 → | May 22, 6:43 pm EDT | John VarianDirector | 8,000 | — | — | 8,000 | — | late |
| Feb 10, 2017 AForm 4 → | May 22, 6:41 pm EDT | Joseph M LimberDirector | 8,000 | — | — | 8,000 | — | late |
| Feb 10, 2017 AForm 4 → | May 22, 6:38 pm EDT | Peter Barton HuttDirector | 8,000 | — | — | 8,000 | — | late |
| Feb 10, 2017 AForm 4 → | May 22, 6:37 pm EDT | W Denman Van NessDirector | 8,000 | — | — | 8,000 | — | late |
| Feb 10, 2017 AForm 4 → | May 22, 6:34 pm EDT | Thomas M. BurnsVP, Finance & CFO | 100,000 | — | — | 100,000 | — | late |
| Feb 10, 2017 AForm 4 → | May 22, 6:27 pm EDT | James R NealCEO, Director | 312,500 | — | — | 312,500 | — | late |
| Dec 22, 2016 AForm 4 → | Dec 23, 6:24 pm EST | Thomas M. BurnsVP, Finance & Chief Financial | 35,000 | — | — | 35,000 | — | |
| Dec 22, 2016 AForm 4 → | Dec 23, 6:07 pm EST | James R NealVP Business Development | 100,000 | — | — | 100,000 | — | |
| Jul 21, 2016 AForm 4 → | Aug 2, 7:38 pm EDT | Timothy P WalbertDirector | 60,532 | — | — | 60,532 | — | late |
| Jul 21, 2016 AForm 4 → | Aug 2, 7:34 pm EDT | Jack L WyszomierskiDirector | 60,532 | — | — | 60,532 | — | late |
| Jul 21, 2016 AForm 4 → | Aug 2, 7:27 pm EDT | W Denman Van NessDirector | 60,532 | — | — | 60,532 | — | late |
| Jul 21, 2016 AForm 4 → | Aug 2, 7:22 pm EDT | W Denman Van NessDirector | 60,532 | — | — | 60,532 | — | late |
| Jul 21, 2016 AForm 4 → | Aug 2, 7:14 pm EDT | Joseph M LimberDirector | 60,532 | — | — | 60,532 | — | late |
| Jul 21, 2016 AForm 4 → | Aug 2, 7:08 pm EDT | Peter Barton HuttDirector | 121,064 | — | — | 121,064 | — | late |
| May 28, 2016 MForm 4 → | May 31, 7:32 pm EDT | Jack L WyszomierskiDirector | 2,800 | — | — | 0 | — | |
| May 28, 2016 MForm 4 → | May 31, 7:28 pm EDT | Timothy P WalbertDirector | 2,800 | — | — | 0 | — | |
| May 28, 2016 MForm 4 → | May 31, 7:25 pm EDT | W Denman Van NessDirector | 3,150 | — | — | 0 | — | |
| May 28, 2016 MForm 4 → | May 31, 7:21 pm EDT | Joseph M LimberDirector | 2,800 | — | — | 0 | — | |
| Mar 18, 2016 MForm 4 → | Mar 22, 9:01 pm EDT | Paul D RubinSr. VP Clinical Dev. & CMO | 12,141 | — | — | 0 | — | |
| Mar 18, 2016 MForm 4 → | Mar 22, 8:58 pm EDT | Patrick J Scannon M.D. Ph.D.Exec. VP & CSO, Director | 9,500 | — | — | 0 | — | |
| Mar 18, 2016 MForm 4 → | Mar 22, 8:55 pm EDT | John VarianCEO, Director | 36,907 | — | — | 0 | — | |
| Dec 12, 2015 MForm 4 → | Dec 15, 4:37 pm EST | Joseph M LimberDirector | 5,600 | — | — | 0 | — | |
| Aug 14, 2015 MForm 4 → | Aug 18, 9:24 pm EDT | John VarianCEO, Director | 94,573 | — | — | 195,239 | — | |
| Aug 14, 2015 MForm 4 → | Aug 18, 9:20 pm EDT | Patrick J Scannon M.D. Ph.D.Exec. VP & CSO, Director | 16,264 | — | — | 38,917 | — | |
| Aug 14, 2015 MForm 4 → | Aug 18, 8:24 pm EDT | Paul D RubinSr. VP Clinical Dev. & CMO | 26,748 | — | — | 0 | — | |
| Jul 15, 2015 MForm 4 → | Jul 17, 6:03 pm EDT | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 70,392 | — | |
| Jul 15, 2015 MForm 4 → | Jul 17, 6:02 pm EDT | Paul D RubinSr. VP Clinical Dev. & CMO | 5,000 | $3.04 | $15,200 | 27,040 | — | |
| Jul 9, 2015 MForm 4 → | Jul 10, 6:57 pm EDT | Paul D RubinSr. VP Clinical Dev. & CMO | 33,400 | $3.04 | $101,536 | 32,040 | — | |
| Jun 15, 2015 MForm 4 → | Jun 17, 3:41 pm EDT | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 80,392 | — | |
| May 28, 2015 MForm 4 → | Jun 1, 6:24 pm EDT | William K Bowes Jr.Director | 5,600 | — | — | 2,800 | — | |
| May 28, 2015 MForm 4 → | Jun 1, 6:24 pm EDT | W Denman Van NessDirector | 6,300 | — | — | 0 | — | |
| May 28, 2015 MForm 4 → | Jun 1, 6:24 pm EDT | Joseph M LimberDirector | 2,800 | — | — | 2,800 | — | |
| May 28, 2015 MForm 4 → | Jun 1, 6:24 pm EDT | Timothy P WalbertDirector | 5,600 | — | — | 0 | — | |
| May 28, 2015 MForm 4 → | Jun 1, 6:24 pm EDT | Jack L WyszomierskiDirector | 5,600 | — | — | 0 | — | |
| May 28, 2015 MForm 4 → | Jun 1, 6:24 pm EDT | Paul D RubinSr. VP Clinical Dev. & CMO | 4,666 | — | — | 0 | — | |
| May 21, 2015 AForm 4 → | May 22, 6:53 pm EDT | William K Bowes Jr.Director | 36,873 | $3.39 | $124,999 | 36,873 | — | |
| May 21, 2015 AForm 4 → | May 22, 6:53 pm EDT | Peter Barton HuttDirector | 73,746 | $3.39 | $249,999 | 73,746 | — | |
| May 21, 2015 AForm 4 → | May 22, 6:53 pm EDT | Joseph M LimberDirector | 36,873 | $3.39 | $124,999 | 36,873 | — | |
| May 21, 2015 AForm 4 → | May 22, 6:52 pm EDT | W Denman Van NessDirector | 36,873 | $3.39 | $124,999 | 36,873 | — | |
| May 21, 2015 AForm 4 → | May 22, 6:52 pm EDT | Timothy P WalbertDirector | 36,873 | $3.39 | $124,999 | 36,873 | — | |
| May 21, 2015 AForm 4 → | May 22, 6:52 pm EDT | Jack L WyszomierskiDirector | 36,873 | $3.39 | $124,999 | 36,873 | — | |
| May 15, 2015 MForm 4 → | May 19, 6:08 pm EDT | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 90,392 | — | |
| Apr 15, 2015 MForm 4 → | Apr 15, 6:50 pm EDT | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 100,392 | — | |
| Apr 6, 2015 MForm 4 → | Apr 7, 7:20 pm EDT | Fred KurlandCFO & VP Finance | 29,938 | — | — | 0 | — | |
| Mar 18, 2015 MForm 4 → | Mar 20, 7:30 pm EDT | Patrick J Scannon M.D. Ph.D.Exec. VP & CSO, Director | 9,500 | — | — | 9,500 | — | |
| Mar 18, 2015 MForm 4 → | Mar 20, 7:30 pm EDT | Thomas KleinChief Commercial Officer | 80,667 | — | — | 80,666 | — | |
| Mar 18, 2015 MForm 4 → | Mar 20, 7:30 pm EDT | Paul D RubinSr. VP Clinical Dev. & CMO | 30,346 | — | — | 0 | — | |
| Mar 18, 2015 MForm 4 → | Mar 20, 7:30 pm EDT | Fred KurlandCFO & VP Finance | 10,875 | — | — | 21,750 | — | |
| Mar 18, 2015 MForm 4 → | Mar 20, 7:30 pm EDT | John VarianCEO, Director | 36,907 | — | — | 36,907 | — | |
| Mar 16, 2015 MForm 4 → | Mar 17, 6:52 pm EDT | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 110,392 | — | |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:42 pm EST | John VarianCEO, Director | 266,800 | $3.83 | $1,021,844 | 266,800 | — | |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:42 pm EST | Thomas KleinChief Commercial Officer | 86,910 | $3.83 | $332,865 | 86,910 | — | |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:42 pm EST | James R NealOther | 72,500 | $3.83 | $277,675 | 72,500 | — | |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:42 pm EST | Patrick J Scannon M.D. Ph.D.Exec. VP & CSO, Director | 52,146 | $3.83 | $199,719 | 52,146 | — | |
| Feb 26, 2015 AForm 4 → | Mar 2, 7:41 pm EST | Paul D RubinSr. VP Clinical Dev. & CMO | 86,910 | $3.83 | $332,865 | 86,910 | — | |
| Feb 17, 2015 MForm 4 → | Feb 19, 6:09 pm EST | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 120,392 | — | |
| Jan 15, 2015 MForm 4 → | Jan 16, 5:22 pm EST | John VarianCEO, Director | 10,000 | $1.24 | $12,400 | 130,392 | — |
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.